Novo Nordisk A/S
GENERATION OF NEURAL STEM CELL LINES DERIVED FROM HUMAN PLURIPOTENT STEM CELLS

Last updated:

Abstract:

The present invention relates generally to the field of stem cells, more specifically to highly pure neural stem cell population, a method for obtaining such highly pure stem cell-derived line of neural stem cells, such as a neural stem cell line derived from pluripotent stem cells, such as human embryonic stem cells. Furthermore, the present invention relates to use of such highly pure neural stem cell lines for use as a medicament for use in the treatment of neurodegenerative diseases.

Status:
Application
Type:

Utility

Filling date:

1 Jul 2020

Issue date:

28 Jul 2022